Arcus Capital Partners, LLC Aziyo Biologics, Inc. Transaction History
Arcus Capital Partners, LLC
- $215 Million
- Q2 2025
A detailed history of Arcus Capital Partners, LLC transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Arcus Capital Partners, LLC holds 30,050 shares of AZYO stock, worth $43,572. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,050
Previous 20,000
50.25%
Holding current value
$43,572
Previous $29,000
48.28%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AZYO
# of Institutions
31Shares Held
17.3MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.45MShares$5 Million2.83% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.18MShares$4.62 Million0.21% of portfolio
-
Silverarc Capital Management, LLC2.67MShares$3.87 Million0.94% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.64MShares$3.83 Million0.02% of portfolio
-
Birchview Capital, LP Burlington, VT1.19MShares$1.72 Million1.55% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...